Outcomes Following Surgery for Complicated Tuberculosis: Analysis of 108 Patients

Abstract

Background Both incidence and complications of pleuropulmonary tuberculosis (TB) have increased due to recent increase of immunocompromising conditions. The aim of this study was to assess surgical outcomes in patients suffering from complicated pleuropulmonary TB.

Methods This study included 108 patients with pleuropulmonary TB who underwent surgery. Age, sex, surgical indications, operative techniques, complications, mortality, and morbidity were evaluated.

Results Male-female ratio was 1:11 with mean age of 40 years; 72.2 and 27.8% of the patients underwent surgery due to parenchymal and pleural complications. In the parenchymal group, the most common indication was parenchymal destruction (27.7%) and the most common procedure was lobectomy (50.9%). Out of 20 sputum smear-positive patients, 15 had multidrug-resistant tuberculosis (MDR-TB) and 5 had smear-positive open cavity. Overall 13 of the MDR-TB group and all smear-positive open cavity group became sputum-negative after the surgery. There were 13 patients with undiagnosed masses, among whom 3 patients had adenocarcinoma. In the pleural group, the most common surgical indication was empyema (13.8%) and the most common procedure was decortication and pleurectomy (13.8%). In the bronchopleural fistula group (6.4%), patients showed good results after surgery.

There were 19.4% of patients who showed postoperative complications. The most common complication was residual space (5.5%). The main factors leading to major postoperative complications included positive preoperative sputum smear and history of immunocompromising condition. Mortality rate was 2.7%.

Conclusion Considering the favorable results achieved by surgery in patients with pleuropulmonary TB, this treatment can be recommended for this group of patients.

Keywords

pleuropulmonary tuberculosis - diagnosis - treatment - complication

• References

• 1 Olcmen A, Gunluoglu MZ, Demir A, Akin H, Kara HV, Dincer SI. Role and outecom of surgery for pulmonary tuberculosis. Asian Cardiovasc Thorac Ann 2006; 14 (5) 363-366
• 2 Souilamas R, Riquet M, Barthes FP, Chehab A, Capuani A, Faure E. Surgical treatment of active and sequelar forms of pulmonary tuberculosis. Ann Thorac Surg 2001; 71 (2) 443-447
• 3 Goble M, Isema MD, Madsen La, Waite D, Ackerson L, Horsburgh Jr. CR. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifamoin. N Engl J Med 1993; 328 (8) 527-532
• 4 Furák J, Troján I, Szöke T , et al. Surgical intervention for pulmonary tuberculosis: analysis of indications and perioperative data relating to diagnostic and therapeutic resections. Eur J Cardiothorac Surg 2001; 20 (4) 722-727
• 5 Freixinet J. Surgical indications for treatment of pulmonary tuberculosis. World J Surg 1997; 21 (5) 475-479
• 6 Takeda S, Maeda H, Hayakawa M, Sawabata N, Maekura R. Current surgical intervention for pulmonary tuberculosis. Ann Thorac Surg 2005; 79 (3) 959-963
• 7 Kerti CA, Miron I, Cozma GV , et al. The role of surgery in the management of pleuropulmonary tuberculosis - seven years’ experience at a single institution. Interact Cardiovasc Thorac Surg 2009; 8 (3) 334-337, discussion 337
• 8 Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993; 328 (8) 521-526
• 9 Rizzi A, Rocco G, Robustellini M, Rossi G, Della Pona C, Massera F. Results of surgical management of tuberculosis: experience in 206 patients undergoing operation. Ann Thorac Surg 1995; 59 (4) 896-900
• 10 Massard G, Roeslin N, Wihlm JM, Dumont P, Witz JP, Morand G. Pleuropulmonary aspergilloma: clinical spectrum and results of surgical treatment. Ann Thorac Surg 1992; 54 (6) 1159-1164
• 11 Pomerantz M. Surgery for the management of Mycobacterium tuberculosis and non-tuberculosis mycobacterial infections of the lung. In: Shields TW, , ed. General Thoracic Surgery. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2002: 1066-1077
• 12 Massard G, Dabbagh A, Wihlm JM , et al. Pneumonectomy for chronic infection is a high-risk procedure. Ann Thorac Surg 1996; 62 (4) 1033-1037, discussion 1037–1038
• 13 Sung SW, Kang CH, Kim YT, Han SK, Shim YS, Kim JH. Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis. Eur J Cardiothorac Surg 1999; 16 (2) 187-193
• 14 Treasure RL, Seaworth BJ. Current role of surgery in Mycobacterium tuberculosis. Ann Thorac Surg 1995; 59 (6) 1405-1407, discussion 1408–1409